Sodium hyaluronate based ophthalmic formulation for use in eye s

Details Sodium hyaluronate based ophthalmic formulation for use in eye s Sodium hyaluronate based ophthalmic formulation for use in eye s

1996-12-20

1999-03-09

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 7804, 514474, 514912, A61K 31715, A61K 3134

Patent

active

058801073

ABSTRACT:
The present invention relates to an ophthalmic formulation, for use in eye surgery, comprising sodium hyaluronate, citrate, at least one antioxidant tolerated by the intraocular tissues and a phosphate buffer.

REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4886786 (1989-12-01), Lindstrom et al.
patent: 4920104 (1990-04-01), Devore et al.
patent: 5409904 (1995-04-01), Hecht et al.
patent: 5614506 (1997-03-01), Falk et al.
Joel Mindel et al. "Therapeuric Review" Jan. Feb. 1990, pp.268-290.
Hermann D. Schubert et al. "Exogenous Na-Hyaluronate in The Anterior Chamber Of The Owl Monkey And Its Effect On The Intraocular Pressure", Apr. 1, 1984. pp. 137-152.

Affiliated with

Also associated with

Rating

Sodium hyaluronate based ophthalmic formulation for use in eye s does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sodium hyaluronate based ophthalmic formulation for use in eye s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sodium hyaluronate based ophthalmic formulation for use in eye s will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1321239